Researchers conducted a cohort study to assess the predictive value of plasma MMP9 in antipsychotic treatment response among patients with schizophrenia.

Alzheimer’s disease robs patients of so much more than their health. It can rewire their personalities and undermine a ...

There are many mechanisms at work here, but the blood sugar increase is probably secondary to the weight gain, rather than ...

A new report that lists what it calls the best nursing homes in the US finds that top-rated facilities continuously excel ...

Negative data cost AbbVie billions of dollars in market value and convinced analysts Bristol Myers had placed a better bet in ...

Shares in AbbVie slumped Monday after the company disclosed its psychiatric medicine emraclidine didn’t best placebo in two ...

A federal judge heard final arguments on Friday as to whether or not a mentally ill arson suspect should be forcibly medicated to try and make him competent to stand trial for a 2021 fire in ...

The state auditor report found poor record keeping and a lack of therapy to accompany psychotropic medications.

Intra-Cellular Therapies’ atypical antipsychotic medication Caplyta has been on a roll, delivering fast commercial growth and coming up triumphant in yet another late-stage trial. | Intra-Cellular ...

Acadia Pharmaceuticals Inc. has persuaded a federal judge to trim claims from investment funds that said the drugmaker misled them into thinking an antipsychotic drug was poised for expanded use , ...

1 When a patient stops taking the culpable medication, symptoms may persist ... 1 Approximately 20% of people who take certain older antipsychotic medications may develop tardive dyskinesia ...